FJX1 may promote endothelial cell capillary formation in a hypoxia-inducible factor 1-dependent manner (Al-Greene et al., 2013; Liu et al., 2020), as well as act as a proto-oncogene that affects metastasis and recurrence in colon cancer patients. This evidence concerns the gene FJX1 and colonic neoplasm.